A timeline for Parkinson's disease.

It is reasonably well established that prior to the motor phase of classical Parkinson's disease (PD) there is a prodromal period of several years duration. Once typical motor features appear, the disease continues up to 20 years depending on multiple variables. The clinical features of the prodromal and motor phases may be correlated with pathological changes in the central and autonomic nervous systems to allow a sequential plan of disease progression. We present a 'best guess' for a typical individual presenting with PD in their sixties and speculate that the disease will last approximately 40 years from the earliest non-motor features to death. Appreciation of this concept may allow better strategies for slowing or halting disease progression.

[1]  J. Holton,et al.  Hyposmia in G2019S LRRK2-related parkinsonism , 2008, Neurology.

[2]  H. Meltzer,et al.  Reduced Levels of Norepinephrine Transporters in the Locus Coeruleus in Major Depression , 1997, The Journal of Neuroscience.

[3]  G. Aston-Jones,et al.  Locus coeruleus and regulation of behavioral flexibility and attention. , 2000, Progress in brain research.

[4]  F. Verhey,et al.  Higher incidence of depression preceding the onset of Parkinson's disease: A register study , 2003, Movement disorders : official journal of the Movement Disorder Society.

[5]  Miguel A Hernán,et al.  Obesity and the risk of Parkinson's disease. , 2004, American journal of epidemiology.

[6]  H. Braak,et al.  Parkinson's disease: a dual‐hit hypothesis , 2007, Neuropathology and applied neurobiology.

[7]  P. Ragonese,et al.  Parkinson disease survival: a population-based study. , 2000, Archives of neurology.

[8]  C. Tanner,et al.  Association of olfactory dysfunction with incidental Lewy bodies , 2006, Movement disorders : official journal of the Movement Disorder Society.

[9]  G. Koob,et al.  Drug addiction: Functional neurotoxicity of the brain reward systems , 2009, Neurotoxicity Research.

[10]  S. Daniel,et al.  Olfactory dysfunction in Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[11]  K. Jellinger A critical reappraisal of current staging of Lewy-related pathology in human brain , 2008, Acta Neuropathologica.

[12]  Bernardo Lanzillo,et al.  Sensory deficit in Parkinson's disease: evidence of a cutaneous denervation. , 2008, Brain : a journal of neurology.

[13]  R. Hauser,et al.  Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease , 2008, Nature Medicine.

[14]  N. Weinberger,et al.  Behavioral memory induced by stimulation of the nucleus basalis: Effects of contingency reversal , 2009, Neurobiology of Learning and Memory.

[15]  Satoshi Orimo,et al.  Axonal α-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease , 2008 .

[16]  M. Shibata,et al.  Cardiac parasympathetic dysfunction concurrent with cardiac sympathetic denervation in Parkinson's disease , 2009, Journal of the Neurological Sciences.

[17]  H. Braak,et al.  Parkinson’s disease: the thalamic components of the limbic loop are severely impaired by α-synuclein immunopositive inclusion body pathology , 2002, Neurobiology of Aging.

[18]  H. Braak,et al.  Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered , 2006, Movement disorders : official journal of the Movement Disorder Society.

[19]  H. Przuntek,et al.  Progress of visual dysfunction in Parkinson's disease , 2002, Acta neurologica Scandinavica.

[20]  K. Jellinger The morphological basis of mental dysfunction in Parkinson's disease , 2006, Journal of the Neurological Sciences.

[21]  José Luis Molinuevo,et al.  Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study , 2006, The Lancet Neurology.

[22]  Elisabet Englund,et al.  Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation , 2008, Nature Medicine.

[23]  R. Doty,et al.  Olfactory dysfunction in parkinsonism , 1988, Neurology.

[24]  C. Tanner,et al.  Excessive daytime sleepiness and subsequent development of Parkinson disease , 2005, Neurology.

[25]  D. Chateau,et al.  Heterotypic sexual behavior in male rats after lesions in different amygdaloid nuclei , 1988, Hormones and Behavior.

[26]  C. Tanner,et al.  Bowel movement frequency in late‐life and incidental Lewy bodies , 2007, Movement disorders : official journal of the Movement Disorder Society.

[27]  Robert E Burke,et al.  A critical evaluation of the Braak staging scheme for Parkinson's disease , 2008, Annals of neurology.

[28]  W. Oertel,et al.  Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. , 2004, Brain : a journal of neurology.

[29]  H. Braak,et al.  Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology , 2006, Neuroscience Letters.

[30]  L. Kessing,et al.  Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study. , 2001 .

[31]  S. Lie,et al.  Mortality and Parkinson disease , 2004, Neurology.

[32]  C. Tanner,et al.  Frequency of bowel movements and the future risk of Parkinson’s disease , 2001, Neurology.

[33]  P. Damier,et al.  Pathological lesions in colonic biopsies during Parkinson’s disease , 2008, Gut.

[34]  D. Dickson,et al.  Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[35]  C. Tanner,et al.  Midlife adiposity and the future risk of Parkinson’s disease , 2002, Neurology.

[36]  A. Thorpe,et al.  Peptides that regulate food intake: regional, metabolic, and circadian specificity of lateral hypothalamic orexin A feeding stimulation. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[37]  K. Jellinger,et al.  α-Synuclein pathology in Parkinson’s and Alzheimer’s disease brain: incidence and topographic distribution—a pilot study , 2003, Acta Neuropathologica.

[38]  I. Alafuzoff,et al.  α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia , 2005, Annals of neurology.

[39]  C. Hawkes Parkinson's disease and aging: Same or different process? , 2008, Movement disorders : official journal of the Movement Disorder Society.

[40]  F. Schmitt,et al.  Lewy Body Pathology in Normal Elderly Subjects , 2009, Journal of neuropathology and experimental neurology.

[41]  H. Braak,et al.  Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered , 2008, Experimental Neurology.

[42]  P. Ragonese,et al.  Long–term survival of Parkinson's disease , 2005, Journal of Neurology.

[43]  A M Stiggelbout,et al.  Patient-reported autonomic symptoms in Parkinson disease , 2007, Neurology.

[44]  K. Chaudhuri,et al.  Non-motor symptoms of Parkinson's disease: diagnosis and management , 2006, The Lancet Neurology.

[45]  A. Kakita,et al.  Degeneration of Cardiac Sympathetic Nerve Begins in the Early Disease Process of Parkinson’s Disease , 2007, Brain pathology.

[46]  Gary Aston-Jones,et al.  Brain structures and receptors involved in alertness. , 2005, Sleep medicine.

[47]  Mark W. Mahowald,et al.  Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder , 1996, Neurology.

[48]  H. Braak,et al.  Invited Article: Nervous system pathology in sporadic Parkinson disease , 2008, Neurology.

[49]  A. Probst,et al.  New insights into the pathology of Parkinson’s disease: does the peripheral autonomic system become central? , 2008, European journal of neurology.

[50]  D. Munoz,et al.  Do α-synuclein aggregates in autonomic plexuses predate Lewy body disorders? , 2007, Neurology.

[51]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[52]  W. Paulus,et al.  Acquired colour deficiency in patients with Parkinson’s disease , 1998, Vision Research.

[53]  C. Hawkes The prodromal phase of sporadic Parkinson's disease: Does it exist and if so how long is it? , 2008, Movement disorders : official journal of the Movement Disorder Society.

[54]  K. Iwanaga,et al.  Lewy body–type degeneration in cardiac plexus in Parkinson’s and incidental Lewy body diseases , 1999, Neurology.

[55]  H. Braak,et al.  Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson's disease. , 2006, Journal of neural transmission. Supplementum.

[56]  Daniel J Schaid,et al.  Survival study of Parkinson disease in Olmsted County, Minnesota. , 2003, Archives of neurology.

[57]  R. Hauser,et al.  Transplanted dopaminergic neurons develop PD pathologic changes: A second case report , 2008, Movement disorders : official journal of the Movement Disorder Society.

[58]  E. Quigley,et al.  Gastrointestinal dysfunction in Parkinson's disease , 1992, Neurology.

[59]  M. Max,et al.  Pain in Parkinson disease , 2004, Neurology.

[60]  R. Postuma,et al.  Manifestations of Parkinson disease differ in association with REM sleep behavior disorder , 2008, Movement disorders : official journal of the Movement Disorder Society.

[61]  G Hu,et al.  Body mass index and the risk of Parkinson disease , 2006, Neurology.

[62]  L. Moran,et al.  Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease. , 2009, Parkinsonism & related disorders.

[63]  E. Rimm,et al.  Erectile function and risk of Parkinson's disease. , 2007, American journal of epidemiology.

[64]  Y. Kayama,et al.  Control of sleep and wakefulness by brainstem monoaminergic and cholinergic neurons. , 2003, Acta neurochirurgica. Supplement.

[65]  I. Alafuzoff,et al.  Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance , 2008, Acta Neuropathologica.

[66]  T. Iwatsubo,et al.  Lewy Body Pathology Involves Cutaneous Nerves , 2008, Journal of neuropathology and experimental neurology.

[67]  H. Berendse,et al.  Idiopathic hyposmia as a preclinical sign of Parkinson's disease , 2004, Annals of neurology.

[68]  Hansjürgen Bratzke,et al.  Stages in the development of Parkinson’s disease-related pathology , 2004, Cell and Tissue Research.

[69]  Thomas Hummel,et al.  Olfactory loss may be a first sign of idiopathic Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[70]  I. Akiguchi,et al.  Spontaneous and artificial lesions of magnocellular reticular formation of brainstem deteriorate avoidance learning in senescence-accelerated mouse SAM , 1998, Brain Research.

[71]  E. Wolters,et al.  Cognitive dysfunction and dementia in Parkinson’s disease , 2004, Journal of Neural Transmission.

[72]  H. Fibiger The Neurobiological Substrates of Depression in Parkinson’s Disease: A Hypothesis , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[73]  S. Isenmann,et al.  Cardiac denervation occurs independent of orthostatic hypotension and impaired heart rate variability in Parkinson's disease. , 2009, Parkinsonism & related disorders.

[74]  M. Marmot,et al.  Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology? , 1995, Journal of neurology, neurosurgery, and psychiatry.

[75]  G. Halliday,et al.  The progression of pathology in longitudinally followed patients with Parkinson’s disease , 2008, Acta Neuropathologica.

[76]  C. Tanner,et al.  Pain in Parkinson's disease , 1986, Movement disorders : official journal of the Movement Disorder Society.

[77]  P. Pahapill,et al.  The pedunculopontine nucleus and Parkinson's disease. , 2000, Brain : a journal of neurology.

[78]  G. Logroscino,et al.  Use of antidepressants and the risk of Parkinson’s disease: a prospective study , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.

[79]  R. Mayeux,et al.  Altered serotonin metabolism in depressed patients with Parkinson's disease , 1984, Neurology.

[80]  J. Sutcliffe,et al.  The hypocretins: Excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding , 2000, Journal of neuroscience research.

[81]  C. van Weel,et al.  Symptoms and duration of the prodromal phase in parkinson's disease , 1997, Movement disorders : official journal of the Movement Disorder Society.

[82]  Alain Dagher,et al.  Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years , 2008, Nature Medicine.

[83]  L. Findley,et al.  Abnormality of taste and smell in Parkinson's disease. , 2009, Parkinsonism & related disorders.

[84]  A. Lees,et al.  Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.

[85]  J. Blundell,et al.  Dose–response effects of orexin-A on food intake and the behavioural satiety sequence in rats , 2000, Regulatory Peptides.

[86]  H. Przuntek,et al.  Early Diagnosis and Preventive Therapy in Parkinson’s Disease , 1989, Key Topics in Brain Research.

[87]  C. Brayne,et al.  Prospective association between emotional health and clinical evidence of Parkinson’s disease , 2008, European journal of neurology.

[88]  H. Braak,et al.  A not entirely benign procedure: progression of Parkinson’s disease , 2008, Acta Neuropathologica.

[89]  H. Braak,et al.  Staging of Sporadic Parkinson Disease-Related α-Synuclein Pathology: Inter- and Intra-Rater Reliability , 2005, Journal of neuropathology and experimental neurology.

[90]  R. Paffenbarger,et al.  Body mass index and risk of Parkinson's disease: a prospective cohort study. , 2007, American journal of epidemiology.

[91]  E. Tolosa,et al.  The premotor phase of Parkinson's disease. , 2007, Parkinsonism & related disorders.

[92]  K. Gwinn‐Hardy,et al.  Pain in Parkinson's disease , 2001, Postgraduate medicine.

[93]  K. Sethi,et al.  Levodopa unresponsive symptoms in Parkinson disease , 2008, Movement disorders : official journal of the Movement Disorder Society.